Shamburg News · 8-K filed Nov 12, 2026, 5:25 PM EST
Aptevo Therapeutics Closes Warrant Inducement Raising About $3.0 Million Gross Proceeds
APVO · Aptevo Therapeutics Inc.
- Material agreement
- Financing
- Materiality: medium
On November 11, 2026, Aptevo Therapeutics Inc. entered into Warrant Inducement and Reload Letters with holders of its August 13, 2026 warrants, under which holders exercised in full for cash 2,777,778 shares at a reduced exercise price of $1.08 per share, for approximately $3.0 million gross proceeds. The Company agreed to issue new unregistered Inducement Warrants for up to 13,888,890 shares at $1.08 per share, exercisable after stockholder approval, which would provide approximately $15.0 million more if fully exercised. The transaction closed on November 12, 2026, and the Company intends to use net proceeds for working capital and general corporate purposes.
Source: SEC EDGAR, Form 8-K, Items 1.01, 3.02, 8.01, 9.01, accession 0001193125-26-458751.
Written from the filing by Shamburg Markets. Figures are as reported by the company.